Citations

Showing 10 of 108081 citations.

International Liver Transplantation Society/Society for Advancement of Transplant Anesthesia Consensus Statement on Essential Attributes of a Liver Transplant Anesthesiologist
Bhangui, Pooja , Pustavoitau, Aliaksei , Sabaté, A. , Wagener, Gebhard , Wray, Christopher , Pan, Terry Ling Te , Nguyen, Christine , Bezinover, Dmitri , Biancofiore, Gíanni , Blasi, Annabel , Chadha, Ryan , Saner, Fuat Hakan , Zerillo, Jeron

Mayo Clinic

Transplantation | March 22, 2023 | Volume: 107 | Issue: 7 | Pages: 1427-1433

10.1097/tp.0000000000004583 | PMID 36944597 Get It

Background. We sought to establish consensus on the essential skills, knowledge, and attributes that a liver transplant (LT) anesthesiologist should possess in a bid to help guide the further training process. Methods. Consensus was achieved via a modified Delphi methodology, surveying 15 identified international experts in the fields of LT anesthesia and critical care. Results. Key competencies were identified in preoperative management and optimization of a potential LT recipient; intraoperative management, including hemodynamic monitoring; coagulation and potential crisis management; and postoperative intensive and enhanced recovery care. Conclusions. This article provides an essential guide to competency-based training of an LT anesthesiologist.
Benchmark test for the characterization of colorectal polyps using a computer‐aided diagnosis with a publicly accessible database
Kamba, Shunsuke , Sumiyama, Kazuki

Mayo Clinic

Digestive Endoscopy | March 22, 2023 | Volume: 35 | Issue: 5 | Pages: 656-657

10.1111/den.14540 | PMID 36944582 Get It

Incidence of spontaneous intracranial hypotension in Olmsted County, Minnesota: 2019–2021
Pradeep, Aishwarya , Madhavan, Ajay A. , Brinjikji, Waleed , Cutsforth‐Gregory, Jeremy K. , Madhavan, Ajay A , Pradeep, Aishwarya

Mayo Clinic

Interventional Neuroradiology | March 22, 2023 | Volume: 31 | Issue: 3 | Pages: 364-368

10.1177/15910199231165429 | PMID 36945844 Get It

Background As the myriad clinical and radiographic presentations of spontaneous intracranial hypotension are increasingly recognized, disease prevalence appears to rise. True incidence data remain insufficient. We sought to calculate the incidence of spontaneous intracranial hypotension among the residents of Olmsted County, Minnesota. Methods Our institution is a quaternary care center for spontaneous intracranial hypotension evaluation and provides primary neurologic care for local residents. All patients who were evaluated at our institution from 2019 to 2021 for spontaneous intracranial hypotension were reviewed, and cases of spontaneous intracranial hypotension with advanced imaging work-up using digital subtraction myelography or dynamic computed tomography myelography were identified. Patients who were residents of Olmsted County were identified. Results Fourteen patients with spontaneous intracranial hypotension were identified in Olmsted County during the study period, all of whom were adults and underwent our institution's standard spontaneous intracranial hypotension work-up. In Olmsted County, the incidence of spontaneous intracranial hypotension was 3.8 per 100,000 adult population, including 3.2 per 100,000 adult females and 2.5 per 100,000 adult males. Seven of 14 patients (50%) had a cerebrospinal fluid-venous fistula. Conclusion This study uniquely presents the incidence rate of spontaneous intracranial hypotension in the general population of Olmsted County, Minnesota. Spontaneous intracranial hypotension is more common in women than men and has an overall incidence roughly equivalent to that of aneurysmal subarachnoid hemorrhage in Olmsted County, a widely known neurologic condition. Approximately half the cases of spontaneous intracranial hypotension are due to cerebrospinal fluid-venous fistulas, which generally require specialty expertise for diagnosis and treatment.
Determining flow stasis zones in the intracranial aneurysms and the relation between these zones and aneurysms’ aspect ratios after flow diversions
Altındağ, Batı , Olcay, Ali Bahadır , Tercanlı, Muhammed Furkan, Bilgin, Cem , Hakyemez, Bahattin , Bahadır Olcay, Ali , Bilgin, Cem

Mayo Clinic

Interventional Neuroradiology | March 22, 2023 | Volume: 31 | Issue: 2 | Pages: 226-234

10.1177/15910199231162878 | PMID 36945841 Get It

Background Flow diverter stents (FDSs) are widely used to treat aneurysms in the clinic. However, even the same flow diverter (FD) use on different patients’ aneurysm sites can cause unexpected hemodynamics at the aneurysm region yielding low success rates for the overall treatment. Therefore, the present study aims to unfold why FDs do not work as they are supposed to for some patients and propose empirical correlation along with a contingency table analysis to estimate the flow stasis zones in the aneurysm sacs. Methods The present work numerically evaluated the use of FRED4518 FDS on six patients’ intracranial aneurysms based on patient-specific aneurysm geometries. Computational fluid dynamics (CFD) simulation results were further processed to identify the time evolution of weightless blood particles for six patients’ aneurysms. Results Stagnation zone formation, incoming and outgoing blood flow at the aneurysm neck, and statistical analysis of six patients indicated that FRED4518 showed a large flow stasis zone for an aspect ratio larger than 0.75. However, FRED4518, used for aneurysms with an aspect ratio of less than 0.65, caused small stagnant flow zones based on the number of blood particles that stayed in the aneurysm sac. Conclusion A patient-specific empirical equation is derived considering aneurysms’ morphological characteristics to determine the amount of stagnated fluid flow zones and magnitude of the mean aneurysm velocity in the aneurysm sac for FRED4518 based on weightless fluid particle results for the first time in the literature. As a result, numerical simulation results and patient data-driven equation can help perceive stagnated fluid zone amount before FRED4518 placement by shedding light on neuro-interventional surgeons and radiologists.
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent MYC and BCL2 and/or BCL6
Zeremski, Vanja , McPhail, Ellen D. , Habermann, Thomas M. , Gebauer, Niklas , Vassilakopoulos, Theodoros P. , Mougiakakos, Dimitrios , Schieppati, Francesca , Gebauer, Niklas , Vassilakopoulos, Theodoros P , Mougiakakos, Dimitrios , McPhail, Ellen Darcy , Habermann, Thomas , Schieppati, Francesca

Mayo Clinic

Hematological Oncology | March 22, 2023 | Volume: 41 | Issue: 4 | Pages: 776-780

10.1002/hon.3130 | PMID 36945194 Get It

Perianal Paget's—an aggressive disease
Rudnicki, Yaron , Stapleton, Sahael M. , Batra, Rishi , Mathis, Kellie L. , Gan, Tong, Kelley, Scott R. , Gan, Tong

Mayo Clinic

Colorectal Disease | March 22, 2023 | Volume: 25 | Issue: 6 | Pages: 1213-1221

10.1111/codi.16549 | PMID 36945125 Get It

Abstract Aim Perianal Paget's disease (PAPD) is a rare disorder with a predisposition to anal and colorectal malignancies and an unclear prognosis. Our previous 25‐year series demonstrated a non‐aggressive nature. This study aims to describe our updated institutional experience. Methods This is a retrospective review of all patients diagnosed with primary PAPD from 1991 to 2021. A prospectively maintained institutional database was searched which included demographics, clinical and pathological manifestations, treatment methods, recurrence, oncological outcome and mortality. Results Thirty patients were diagnosed with PAPD. Fifteen were women (50%); the average age at diagnosis was 71 ± 10.7 years, and the average lesion size was 3.7 ± 2.6 cm. At diagnosis, 12 (40%) were harbouring invasive anal adenocarcinoma. Eight (27%) developed adenocarcinomas concurrent with PAPD recurrence at a mean interval of 9 ± 4.4 years (range 1.9–14.8). The Kaplan–Meier curve estimated overall survival of 93%, 86%, 82%, 65% and 56% at 1, 3, 5, 10 and 15 years, respectively. Median survival was 16 years. Six (20%) had disease‐related mortality. Initially, nine (30%) were treated with abdominoperineal resection (APR), 15 (50%) underwent local resection, three (10%) were treated with radiotherapy, two (7%) received only topical therapy and one (3%) chose observation. Fifteen (50%) experienced recurrence of PAPD, two after undergoing APR. Five (17%) had persistent disease until death. Only 10 (33%) did not experience PAPD recurrence, seven of whom underwent APR. The mean follow‐up time was 9.2 ± 6.2 years. Conclusions Perianal Paget's disease is an aggressive entity with high rates of synchronous anal adenocarcinoma at diagnosis and development of metachronous adenocarcinoma later in life.
Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality
Long, Lu , Lee, Jeffrey K. , Lai, Michelle , Yang, Wanshui , Roberts, Lewis R. , Zhang, Xuehong , Roberts, Lewis R , Liu, Xing , Petrick, Jessica L. , Liu, Wanqing , Liao, Linda M. , Libermann, Towia A. , McGlynn, Katherine A. , Tabung, Fred K.

Mayo Clinic

JNCI Cancer Spectrum | March 21, 2023 | Volume: 7 | Issue: 2 | Pages: No page available

10.1093/jncics/pkad023 | PMID 36943385 Get It

Abstract Background Diet modulates inflammation and insulin response and may be an important modifiable factor in the primary prevention of hepatocellular carcinoma (HCC) and chronic liver disease (CLD). We developed the empirical dietary inflammatory pattern (EDIP) and empirical dietary index for hyperinsulinemia (EDIH) scores to assess the inflammatory and insulinemic potentials of diet. We prospectively examined the associations of EDIP and EDIH at baseline with the following HCC risk and CLD mortality. Design We followed 485 931 individuals in the National Institutes of Health–American Association of Retired Persons Diet and Health Study since 1995. Cox proportional hazards regression was used to calculate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs). Results We confirmed 635 incident HCC cases and 993 CLD deaths. Participants in the highest compared with those in the lowest EDIP quartile had a 1.35 times higher risk of developing HCC (95% CI = 1.08 to 1.70, Ptrend = .0005) and a 1.70 times higher CLD mortality (95% CI = 1.41 to 2.04, Ptrend < .0001). For the same comparison, participants with the highest EDIH were at increased risk of HCC (HR = 1.53, 95% CI = 1.20 to 1.95, Ptrend = .0004) and CLD mortality (HR = 1.72, 95% CI = 1.42 to 2.01, Ptrend < .0001). Similar positive associations of scores with HCC risk and CLD mortality were observed for both women and men. Moreover, individuals in both the highest EDIP and EDIH tertiles had a 92% increased HCC risk (95% CI = 1.43 to 2.58) and 98% increased CLD mortality (95% CI = 1.27 to 3.08) compared with those in both lowest tertiles. Conclusions Our findings suggest that inflammation and hyperinsulinemia are potential mechanisms linking diet to HCC development and CLD mortality.
Rare benign adrenal lesions
Dogra, Prerna , Bancos, Irina , Sundin, Anders , Juhlin, C. Christofer , Calissendorff, Jan , Falhammar, Henrik , Bancos, Irina

Mayo Clinic

European Journal of Endocrinology | March 21, 2023 | Volume: 188 | Issue: 4 | Pages: 407-420

10.1093/ejendo/lvad036 | PMID 36943310 Get It

AbstractWhile most benign lesions of the adrenal glands represent either an adrenocortical adenoma or a myelolipoma, the advent and frequent use of high-resolution radiological investigations have led to relatively increased incidental discovery of rare adrenal lesions, specifically benign adrenal cysts, adrenal ganglioneuromas, adrenal schwannomas, adrenal hemorrhage, and adrenal calcifications. Radiological characteristics of the different rare benign adrenal lesions could vary from distinct to indeterminate. Though typically nonfunctional, these rare lesions require evaluation for adrenal hormone excess, as they may phenotypically appear similar to pheochromocytoma or adrenocortical carcinoma and could sometimes be associated with or conceal an underlying functional adrenal tumor. In this review, we discuss the various rare benign adrenal lesions, emphasizing a practical perspective.
Lack of significant Lewy pathology in 237 essential tremor brains
Shill, Holly A. , Tremblay, Cécilia , Beach, Thomas G. , Adler, Charles H.

Mayo Clinic

Journal of Neuropathology & Experimental Neurology | March 21, 2023 | Volume: 82 | Issue: 5 | Pages: 452-453

10.1093/jnen/nlad022 | PMID 36943272 Get It

Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
Jain, Tania , Tsai, Hua‐Ling , Elmariah, Hany , Vachhani, Pankit , Wall, Sarah , Gondek, Lukasz P. , Bashey, Asad, Keyzner, Alla , Tamari, Roni , Nadiminti, Kalyan , Ali, Haris , Jones, Richard J. , Gondek, Lukasz , Tamari, Roni , Grunwald, Michael , Gerds, Aaron T , McCurdy, Shannon , Al Malki, Monzr M , Ali, Haris , Gupta, Vikas , Jain, Tania , Elmariah, Hany , Karantanos, Theodoros , Grunwald, Michael R. , Abedin, Sameem , Iqbal, Madiha , Gerds, Aaron T. , Viswabandya, Auro , Malki, Monzr M. Al , Varadhan, Ravi , Gupta, Vikas , Otoukesh, Salman

Mayo Clinic

No container title available | March 21, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2691216/v1 | PMID 36993719 Get It

AbstractHaploidentical donors offer a potentially readily available donor, especially for non-White patients, for blood or marrow transplantation (BMT). In this collaboration across North America, we retrospectively analyzed outcomes of first BMT using haploidentical donor and posttransplantation cyclophosphamide (PTCy) in MDS/MPN-overlap neoplasms (MDS/MPN), an otherwise incurable hematological neoplasm. We included 120 patients, 38% of non-White/Caucasian ethnicity, across 15 centers with median age at BMT 62.5 years. The median follow-up is 2.4 years. Graft failure was reported in 6% patients. At 3-years, nonrelapse mortality (NRM) was 25%, relapse 27%, grade 3-4 acute graft versus host disease (GVHD) 12%, chronic GVHD requiring systemic immunosuppression 14%, progression-free survival (PFS) 48% and overall survival (OS) 56%. On multivariable analysis, statistically significant associations included older age at BMT (per decade increment) with NRM (sdHR 3.28, 95%CI 1.30-8.25), PFS (HR 1.98, 95% 1.13-3.45) and OS (HR 2.01, 95% CI 1.11-3.63), presence of mutation in EZH2/RUNX1/SETBP1 with relapse (sdHR 2.61, 95%CI 1.06-6.44), and splenomegaly at BMT/prior splenectomy with OS (HR 2.20, 95%CI 1.04-4.65). Haploidentical donors are a viable option for BMT in MDS/MPN, especially for those disproportionately represented in the unrelated donor registry. Disease-related factors including splenomegaly and high-risk mutations dominate outcomes following BMT.